Fortrea Holdings Inc. (FTRE) vs Harmony Biosciences Holdings, Inc. (HRMY)

A side-by-side comparison of Fortrea Holdings Inc. and Harmony Biosciences Holdings, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — FTRE vs HRMY

growth of $100 · dividends reinvested · last 3y
FTRE -34.0% (-12.9%/yr)HRMY +9.3% (+3.0%/yr)HRMY compounded faster over this window
50100Start $100202420252026$66$109
FTRE HRMY

FTRE vs HRMY: by the numbers

  • •HRMY is the larger company ($2.29B vs $2.04B market cap).
  • •HRMY is profitable (18.88% net margin) while FTRE runs a net loss (-3.18%).
  • •HRMY grew revenue faster over the past five years (32.47% vs 1.09% CAGR).

Metrics side by side

Valuation

MetricFTREHRMY
P/E ratioN/A12.84
Forward P/E25.5310.03
P/S ratio0.762.39
P/B ratio3.902.29
EV / EBITDA33.497.40
FCF yield7.38%15.50%

Profitability

MetricFTREHRMY
Gross margin17.11%75.42%
Operating margin0.41%24.03%
Net margin-3.18%18.88%
ROE-16.25%18.14%
ROIC0.62%14.96%

Growth (annualized)

MetricFTREHRMY
Revenue CAGR (5Y)1.09%32.47%
FCF CAGR (5Y)-12.98%48.43%
Total return CAGR (5Y)N/A0.91%

Frequently asked

Which has grown faster, FTRE or HRMY?
Over the past five years, HRMY grew revenue faster — FTRE at a 1.09% CAGR versus HRMY at 32.47%.
Is FTRE or HRMY more profitable?
HRMY runs the higher net margin — FTRE at -3.18% versus HRMY at 18.88%.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.